Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE
Completed
Conditions studied: NAFLD, NASH - Nonalcoholic Steatohepatitis
In brief
Magnetic resonance imaging (MRI) is used to measure liver fat content and fatty tissues in the body, and magnetic resonance elastography (MRE) is used to measure liver stiffness. The information from MRI and MRE are used to understand risk factors and diagnose liver diseases, such as fatty liver disease and liver fibrosis. However, current MRI and MRE scans need to be performed during a breath-hold, which may be challenging or impossible in children and infants. The goal of this research project is to develop and evaluate new free-breathing MRI and MRE technology to improve the comfort and diagnostic accuracy for children and infants.
Key facts
- Study ID
- NCT04591106
- Run by
- University of California, Los Angeles
- People needed
- 135
- Starts
- 2021-02-17
- Expected to finish
- 2026-02-28
- Last updated by the study team
- 2026-03-10
Who can join
Age: 0 and older, up to 40. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- children and adults 1 month-40 years of age
- liver disease and suspected or confirmed fibrosis
- clinically ordered liver biopsy
- Liver diseases include NAFLD/NASH, viral/medication induced hepatitis, autoimmune sclerosing cholangitis, intestinal failure associated liver disease, idiopathic hepatitis, Wilson's disease, hemosiderosis, liver rejection, and metabolic/genetic disorders
- A liver biopsy must be planned/anticipated, performed, or scheduled to be performed within ±6 months of the MRI/MRE for this study
You may not qualify if…
- contra-indications to MRI/MRE
- inability to perform breath-holding
- Study 3 (Aim 4):
- Inclusion criteria for the cohort of infants at risk for future obesity and NAFLD:
- 1 week-6 months of age
- greater than or equal to 35 weeks gestational age
- born to a mother with gestational diabetes and whose pre-pregnancy body mass index >=25 kg/m2
- mother must provide consent to participate in the study
- Inclusion criteria for the healthy cohort:
- 1 week-6 months of age
- greater than or equal to 35 weeks gestational age
- appropriate for gestational age birth weight
- born to a mother with a pre-pregnancy body mass index <25 kg/m2 and without any major co-morbid conditions (gestational diabetes, pregnancy-induced hypertension, etc.)
- admitted to the newborn nursery after birth
- mother must provide consent to participate in the study
- Exclusion criteria for both cohorts:
- known liver disease and/or infection, major congenital anomalies, inborn error of metabolism
- any contraindications for an MRI exam
Where it is running
- UCLA Medical Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.